Magnurol

Terazosin, the active ingredient in Magnurol, is a Alpha-1 adrenergic blocker presented as a tablet for oral use. It is employed to lower high blood pressure and to improve urinary flow in men with an enlarged prostate. GNH USA supplies Magnurol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terazosin acts on the alpha‑1 adrenergic pathway to manage cardiovascular and urological conditions. - Hypertension: reduces systemic vascular resistance to lower blood pressure. - Benign prostatic hyperplasia: relaxes smooth muscle in the prostate and bladder neck to improve urine flow. - Elevated systolic blood pressure: assists patients in reaching target systolic levels as part of antihypertensive therapy.

Terazosin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nasal congestion - Peripheral edema - Nausea

Serious or Rare Side Effects: - Orthostatic hypotension leading to fainting - Priapism (prolonged erection) - Severe liver injury (rare) - Anaphylactic reaction - Exacerbation of heart failure - Syncope

Before initiating therapy, clinicians should evaluate several safety considerations. - Blood pressure monitoring: check baseline and periodic readings. - Prostate assessment: confirm diagnosis of BPH before use. - Concomitant antihypertensives: adjust doses to avoid excessive hypotension. - Hepatic function: use caution in patients with liver impairment. - Discontinuation: avoid abrupt stopping to prevent rebound hypertension. - Store at ambient temperature: keep in original container, protect from moisture.

Terazosin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other alpha‑1 blockers (e.g., prazosin) – additive hypotensive effect. - Potent CYP3A4 inhibitors (e.g., ketoconazole) – increased plasma levels. - PDE5 inhibitors (e.g., sildenafil) – risk of severe hypotension.

Moderate Interactions (Monitor Closely):\n- Lithium – possible increase in lithium concentrations. - Diuretics – may enhance orthostatic blood pressure drops.